Docor International Management

Founded in 2012 and based in Rehovot, Israel, Raziel Therapeutics develops RZL-012, a novel synthetic small molecule for treating obesity. Its drug is injected into fat tissue, causing fat cell death at the injection site and resulting in long-lasting reduction of fat volume.

SP Nano Ltd. is a nanotechnology company based in Yavne, Israel, founded in 2007, that specializes in developing advanced materials for various industries. The company focuses on enhancing textiles and composite materials by utilizing a proprietary protein technology that integrates carbon nanotubes into a range of fabrics, including carbon fiber, aramid, and glass fiber composites. Its flagship product, SP1, serves as a nano-reinforcement agent designed to improve the strength and sustainability of components used in aerospace, automotive, and energy applications. By addressing the weaknesses in traditional composite materials, SP Nano enables the production of lighter, stronger, and more cost-effective parts, contributing to the growing composites market.

Colospan is a medical device company specializing in colorectal surgery. Founded in 2010, it develops innovative products to prevent anastomotic leaks and diverting colonic stomas during intestinal surgeries.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

SP Nano Ltd. is a nanotechnology company based in Yavne, Israel, founded in 2007, that specializes in developing advanced materials for various industries. The company focuses on enhancing textiles and composite materials by utilizing a proprietary protein technology that integrates carbon nanotubes into a range of fabrics, including carbon fiber, aramid, and glass fiber composites. Its flagship product, SP1, serves as a nano-reinforcement agent designed to improve the strength and sustainability of components used in aerospace, automotive, and energy applications. By addressing the weaknesses in traditional composite materials, SP Nano enables the production of lighter, stronger, and more cost-effective parts, contributing to the growing composites market.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

Check-Cap Ltd. is a clinical-stage medical diagnostics company based in Isfiya, Israel, specializing in the development of innovative solutions for colorectal cancer screening. The company's flagship product, the C-Scan system, is a capsule-based technology that utilizes low-dose X-rays to detect colonic polyps and colorectal cancers without the need for bowel preparation or invasive procedures. The C-Scan system consists of three components: the C-Scan Cap, an ingestible capsule that collects and transmits imaging data; the C-Scan Track, a biocompatible device worn by the patient to track the capsule's movement and record data; and C-Scan View, software designed to process and visualize the captured clinical data. This preparation-free approach is intended to provide accuracy comparable to traditional colonoscopy, with the capsule passing naturally through the gastrointestinal tract. Check-Cap aims to bring its technology to markets in the United States, Europe, Israel, and Japan.

SP Nano Ltd. is a nanotechnology company based in Yavne, Israel, founded in 2007, that specializes in developing advanced materials for various industries. The company focuses on enhancing textiles and composite materials by utilizing a proprietary protein technology that integrates carbon nanotubes into a range of fabrics, including carbon fiber, aramid, and glass fiber composites. Its flagship product, SP1, serves as a nano-reinforcement agent designed to improve the strength and sustainability of components used in aerospace, automotive, and energy applications. By addressing the weaknesses in traditional composite materials, SP Nano enables the production of lighter, stronger, and more cost-effective parts, contributing to the growing composites market.

SimilarWeb provides an AI-driven market intelligence platform that monitors web and mobile app traffic to help organizations understand, track, and grow their digital market share. The platform offers global, multi-device insights into a website’s statistics and competitive strategy, enabling data-driven decisions. Founded in 2007 and based in New York, the company operates worldwide with offices in Israel, the United Kingdom, France, Japan, and Australia. SimilarWeb derives most of its revenue from subscription-based access to its digital data and analytics platform and related products, serving customers across the United States and other regions including Europe and Asia Pacific.

OCON Healthcare, also known as OCON Medical Ltd., specializes in developing and manufacturing innovative women's health products centered around its proprietary Intra Uterine Ball (IUB) platform. Key offerings include the IUB Ballerine, a hormone-free, copper-based intrauterine contraceptive effective for five years, and the OCON SEAD, which is currently undergoing Phase II clinical studies for treating abnormal uterine bleeding. The IUB platform, constructed from a super-elastic alloy, serves as an effective carrier for various therapeutic substances targeting conditions such as heavy menstrual bleeding, fibroids, and infertility. The company distributes its contraceptive products primarily in Europe, South Africa, and Israel. Founded in 2011, OCON Healthcare operates from its headquarters in Modi'in-Maccabim-Re'ut, Israel, and maintains an additional office in Zürich, Switzerland.

EarlySense Ltd. is a developer of advanced patient monitoring systems tailored for hospitals, healthcare systems, integrated delivery networks, and rehabilitation centers. Founded in 2004 and based in Ramat Gan, Israel, with additional offices in Woburn, Massachusetts, the company specializes in signal-processing technology that enhances patient safety and facilitates early detection of health deterioration. Its flagship product, the EarlySense System, offers continuous monitoring of heart rate, respiratory rate, and patient motion, allowing clinical teams to manage risks such as falls and pressure ulcers. Additionally, the Central Display Station enables nursing staff to supervise patients effectively, while the contact-free consumer health monitor, known as LIVE, provides users and caregivers with insights into heart health, breathing cycles, and sleep quality. The company's offerings, including EarlySense Live, cater to a variety of healthcare environments and are distributed in Israel, the United States, and Australia. EarlySense has established a strategic partnership with Welch Allyn to further enhance its product capabilities.

SP Nano Ltd. is a nanotechnology company based in Yavne, Israel, founded in 2007, that specializes in developing advanced materials for various industries. The company focuses on enhancing textiles and composite materials by utilizing a proprietary protein technology that integrates carbon nanotubes into a range of fabrics, including carbon fiber, aramid, and glass fiber composites. Its flagship product, SP1, serves as a nano-reinforcement agent designed to improve the strength and sustainability of components used in aerospace, automotive, and energy applications. By addressing the weaknesses in traditional composite materials, SP Nano enables the production of lighter, stronger, and more cost-effective parts, contributing to the growing composites market.

MacroCure is a biotechnology company specializing in advanced cell therapy products for wound care. Its innovative approach uses activated white blood cells from healthy donors to promote natural wound healing.

EarlySense Ltd. is a developer of advanced patient monitoring systems tailored for hospitals, healthcare systems, integrated delivery networks, and rehabilitation centers. Founded in 2004 and based in Ramat Gan, Israel, with additional offices in Woburn, Massachusetts, the company specializes in signal-processing technology that enhances patient safety and facilitates early detection of health deterioration. Its flagship product, the EarlySense System, offers continuous monitoring of heart rate, respiratory rate, and patient motion, allowing clinical teams to manage risks such as falls and pressure ulcers. Additionally, the Central Display Station enables nursing staff to supervise patients effectively, while the contact-free consumer health monitor, known as LIVE, provides users and caregivers with insights into heart health, breathing cycles, and sleep quality. The company's offerings, including EarlySense Live, cater to a variety of healthcare environments and are distributed in Israel, the United States, and Australia. EarlySense has established a strategic partnership with Welch Allyn to further enhance its product capabilities.

SimilarWeb provides an AI-driven market intelligence platform that monitors web and mobile app traffic to help organizations understand, track, and grow their digital market share. The platform offers global, multi-device insights into a website’s statistics and competitive strategy, enabling data-driven decisions. Founded in 2007 and based in New York, the company operates worldwide with offices in Israel, the United Kingdom, France, Japan, and Australia. SimilarWeb derives most of its revenue from subscription-based access to its digital data and analytics platform and related products, serving customers across the United States and other regions including Europe and Asia Pacific.

Aposense Ltd. is a biopharmaceutical company based in Petah Tikva, Israel, specializing in the development of innovative drugs that leverage the unique structural and electrical properties of biological membranes. Founded in 1996, Aposense focuses on creating molecular nano-motors capable of harnessing energy from intra-membrane electric fields to facilitate the delivery of genetic drugs, such as siRNA, into cells. The company has developed a platform technology known as Apo-Si, which supports targeted therapy and real-time clinical imaging of disease activity, particularly in oncology, cardiology, and neurology. Aposense is also advancing its proprietary drug candidate, ATT-11T, a conjugate designed to treat solid tumors by combining a molecular nano-motor with SN-38, the active component of irinotecan. With its commitment to transforming apoptosis targeting into practical applications, Aposense is at the forefront of integrating advanced therapeutic strategies into personalized patient care.

CollPlant Biotechnologies Ltd. is a regenerative medicine company specializing in the 3D bioprinting of tissues and organs, as well as medical aesthetic products. Headquartered in Rehovot, Israel, the company utilizes its proprietary plant-based genetic engineering technology to produce recombinant human collagen (rhCollagen). CollPlant's product offerings include BioInks for tissue and organ bioprinting, a dermal filler for wrinkle treatment, 3D bioprinted breast implants, and the Vergenix line, which features a soft tissue repair matrix for tendinopathy and an advanced wound care product designed for various chronic wounds. Founded in 2004, CollPlant aims to address diverse needs in the fields of tissue repair and aesthetics across the United States, Canada, and Europe.

Einstein is a K-12 STEM education company that specializes in providing an innovative learning platform designed to enhance science education. The company offers the einstein Learning Platform, which combines sensor-based experiments with interactive multimedia, creating an engaging learning environment for students. Central to this platform is the einstein Tablet+2, equipped with 10 built-in sensors and the capability to connect to additional external sensors, making it suitable for various scientific curricula. The platform is designed with Common Core standards in mind, allowing it to be utilized in both traditional science labs and broader educational settings. Additionally, the platform includes software and apps that support interactive, self-guided activities for students, empowering teachers to deliver science education in a meaningful and effective manner. With over 20 years of experience in science education technology, Einstein leverages advanced sensors and data analysis tools to enhance the learning experience.

MentorWave Technologies Ltd. develops, manufactures, and markets 3D visualization solutions. The company's product MENTORIA is a visualization platform that enables users to overcome obsolete visual documentation and interact with distant sites. MentorWave Technologies was founded in 2002 and is based in Herzelya, Israel.

CollPlant Biotechnologies Ltd. is a regenerative medicine company specializing in the 3D bioprinting of tissues and organs, as well as medical aesthetic products. Headquartered in Rehovot, Israel, the company utilizes its proprietary plant-based genetic engineering technology to produce recombinant human collagen (rhCollagen). CollPlant's product offerings include BioInks for tissue and organ bioprinting, a dermal filler for wrinkle treatment, 3D bioprinted breast implants, and the Vergenix line, which features a soft tissue repair matrix for tendinopathy and an advanced wound care product designed for various chronic wounds. Founded in 2004, CollPlant aims to address diverse needs in the fields of tissue repair and aesthetics across the United States, Canada, and Europe.

CritiSense, Ltd., founded in 2004 and based in Giv'at Shmu'el, Israel, develops medical devices for real-time monitoring of patients' metabolic states. Its flagship product, CritiView, is a monitoring system that provides continuous, real-time information via four physiological parameters sensed at the tissue level. This data reflects the patient’s systemic metabolic state and helps identify imbalances in tissue and body vitality. The device is used by surgeons, anesthesiologists, and caregivers in intensive care units to enhance surgical outcomes and patient care. CritiView monitors mitochondrial function, microcirculatory blood flow, and oxygen saturation using an optical sensor, offering valuable insights into a patient's physiological status during critical procedures or intensive care.

CogniTens, Ltd. specializes in three-dimensional optical measurement solutions aimed at enhancing manufacturing processes, particularly in the automotive sector. The company offers a range of products, including Optigo, a portable measurement platform for direct use by operators and engineers, and OptiCell, an automated system for off-line recurring measurements of parts and assemblies. Additionally, CogniTens provides comprehensive software solutions such as CoreView Plan for planning measurement programs, CoreView Pro for analyzing and reporting data, and CoreView Lite for viewing measurement results. These systems are designed to support various industrial engineering activities, including tooling, part production, assembly, and quality control. Established in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens serves a wide array of clients, including automotive OEMs, tier-1 suppliers, and tool and die companies, with a global presence that includes offices across North America, South America, Europe, and Asia.

Protalix Biotherapeutics is a biopharmaceutical company based in Karmiel, Israel, specializing in the development and commercialization of recombinant therapeutic proteins using its proprietary ProCellEx plant cell-based protein expression system. The company is known for its product Elelyso, a plant-expressed recombinant glucocerebrosidase enzyme approved for treating Gaucher disease. Protalix is advancing a diverse pipeline that includes PRX-102, currently in phase III trials for Fabry disease, and OPRX-106, an orally delivered protein candidate for inflammatory bowel disease. Other products in development include PRX-110 for cystic fibrosis and PRX-115 for gout. Protalix has established partnerships with notable organizations, including Pfizer, which collaborates on the development and commercialization of Elelyso outside of Israel. Founded in 1993, Protalix is focused on addressing significant medical needs through its innovative biopharmaceutical solutions.

CogniTens, Ltd. specializes in three-dimensional optical measurement solutions aimed at enhancing manufacturing processes, particularly in the automotive sector. The company offers a range of products, including Optigo, a portable measurement platform for direct use by operators and engineers, and OptiCell, an automated system for off-line recurring measurements of parts and assemblies. Additionally, CogniTens provides comprehensive software solutions such as CoreView Plan for planning measurement programs, CoreView Pro for analyzing and reporting data, and CoreView Lite for viewing measurement results. These systems are designed to support various industrial engineering activities, including tooling, part production, assembly, and quality control. Established in 1995 and headquartered in Ramat Hasharon, Israel, CogniTens serves a wide array of clients, including automotive OEMs, tier-1 suppliers, and tool and die companies, with a global presence that includes offices across North America, South America, Europe, and Asia.

HumanEyes Technologies, Ltd. specializes in providing an end-to-end solution for the creation and printing of 3D and 2D effects, catering to photographers, graphic artists, and printers. The company leverages its extensive experience in the lenticular segment to develop innovative software that enhances creativity and productivity while maintaining efficiency. In addition to its software offerings, HumanEyes develops 3D VR cameras equipped with proprietary stitching algorithms and real-time rendering engines, facilitating the easy creation and sharing of virtual and augmented reality content. With a strong and diverse talent pool, the company operates globally, with offices in the US, Japan, and Europe, ensuring that it delivers sales, training, and support in close proximity to its customers and in their native languages.